ARCHIVES

Clolar Approved for Pediatric Refractory/Relapsed ALL

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

Hugh Creech, Fox Chase Chemotherapy Pioneer, Dead at 92

January 31, 2003

Judge Invalidates Bristol-Myers’ Claims For The Administration Of Taxol.

March 3, 2000

Oral Capecitabine Equal To 5FU-Leucovorin In Adjuvant Stage III Colon Cancer Treatment

June 25, 2004

Blistering Resignation Letters Declare CPRIT Outside Mainstream of Science

October 12, 2012

NCI Director John Niederhuber Favors Hands-On Management, Revives Institute’s Former Organizational Structure, Abandons Senior Management Team to Work Closely With Deputies and Division Directors.

September 22, 2006

In Brief: ACS to Spend Record $85 Million On Research: AACR To Honor Hanafusa, DeVita, Barbacid

March 14, 1986